As 2025 comes to a close, we want to extend our heartfelt gratitude to all our patient partners, clinicians, researchers, and collaborators across the globe. Your dedication continues to drive our shared mission forward and brings real hope to families living with rare neuromuscular diseases.

Explore what PROMOT’s scoping reviews revealed about CMS and CM – and how these insights are shaping future rare disease research and data models.

Discover how the PROMOT project is transforming rare neuromuscular disease research through a patient-centered, multi-country approach. Learn about its innovative LEAP platform, interdisciplinary methods, and goals to identify new therapeutic targets.